'김갑성' 기자의 전체기사
-
K-Beauty & K-MediTech Expo Malaysia 2025 Concludes Succ…
PENANG, Malaysia, Nov. 28, 2025 -- K-Beauty Expo Malaysia 2025 and K-MediTech Expo Malaysia 2025, hosted by Gyeonggi Province and organised by KINTEX, have successfully concluded at the Penang Waterfront Convention Centre (PWCC) after a dynamic three-day showcase of Korea's leading beauty and medical innovations. Making their Malaysian debut, the dual expos drew thousands of visitors, buyers, healthcare professionals, and beauty enthusiasts from across Southeast Asia. The opening ceremony was graced by distinguished VIPs, including Mr. Sang-woo Hong, Ambassador for Internationa
- 김갑성 기자
- 2025-11-28 20:11
-
Tianlong Strengthens Transfusion Safety with Innovative Blo…
XI'AN, China, Nov. 28, 2025 -- On World AIDS Day 2025, Tianlong reiterates its commitment to advancing global transfusion safety by presenting its fully integrated nucleic acid blood screening solution. Combining high automation with high-sensitivity NAT reagents, the solution enables earlier detection of low-viral-load infections—an essential step in reducing transfusion-transmitted HIV and safeguarding patients who rely on safe blood. Strengthening Blood Safety Through Earlier Detection Ensuring blood safety remains one of the most effective defenses against transfusio
- 김갑성 기자
- 2025-11-28 18:33
-
SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Ea…
TAIPEI, Nov. 28, 2025 -- Precision medicine is entering a new era, driven by breakthroughs in genetic technology and Artificial Intelligence (AI). Multi-Cancer Early Detection (MCED) has become a global trend, and Taiwan joins this movement with the introduction of SPOT-MAS - an advanced screening solution developed by Gene Solutions, a global leader in precision oncology and genomics, in collaboration with local partner Gene Health. The launch event, "Gene Solutions • Decoding Tomorrow - SPOT-MAS Taiwan Launch & Sharing Session," held on November 22, brought together lea
- 김갑성 기자
- 2025-11-28 16:03
-
OMRON Healthcare Surpasses 50 Million Nebulizers Sold
[ 메디채널 김갑성 기자 ] - Easing Burden of Respiratory Diseases Worldwide since 1978 - KYOTO, Japan, Nov. 28, 2025 -- OMRON HEALTHCARE Co., Ltd., a global leader in the field of clinically proven, innovative medical equipment for home health monitoring and treatment, announced that cumulative sales of its nebulizers have surpassed 50 million units. This proud milestone underscores the company's long-standing commitment to helping people around the world to live healthier lives through management of respiratory conditions. Image1: https://cdn.kyodonewsprwire.jp/prwfile/release/M000242/
- 김갑성 기자
- 2025-11-28 16:00
-
Yale-Trained Neuroscientist Unveils "Digital Sunshine" Devic…
[ 메디채널 김갑성 기자 ] Panbrain Lume Offers a Drug-Free Path to Deeper Sleep and Faster Sleep Onset in Just 8 Minutes, Now Live on Kickstarter NEW HAVEN, Conn., Nov. 28, 2025 -- In a bold fusion of cutting-edge neuroscience and ancient Eastern wellness principles, Dr. Nailin Yao, a former Yale postdoctoral fellow in psychiatry, today announces the launch of Panbrain Lume. This revolutionary intranasal near-infrared (NIR) photobiomodulation device is designed to combat the global sleep crisis with a simple, 8-minute nightly routine. Backed by robust science, Panbrain Lume is clinically engin
- 김갑성 기자
- 2025-11-28 14:20
-
Imugene and JW Therapeutics Announce a Collaboration…
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. The collaboration includes preclinical studies, followed by a Phase 1 investigator-initiated trial (IIT) in China targeting difficult-to-treat cancers. This approach represents a first-in-class "mark and kill" strategy, leveraging oncolytic virus-induced CD19 expression to make solid tumors targetable by CD19-CAR T cells.
- 김갑성 기자
- 2025-11-28 13:00
-
The Annals of Oncology Publishes Results of Phase II Stud…
CHENGDU, China, Nov. 28, 2025 -- Recently, Clinical study results from Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990)'s TROP2 ADC sacituzumab tirumotecan (sac-TMT) monotherapy for advanced or metastatic urothelial carcinoma (UC) patients has been published in the journal of Annals of Oncology (Impact Factor: 65.4). This study provides the first evidence of sac-TMT's potential significant clinical benefit for patients with advanced UC. This publication is based on the efficacy and safety results of cohort 9 of a phase II M
- 김갑성 기자
- 2025-11-28 12:32
-
Sarawak to Host the Inaugural Asia Pacific Aerospace Confe…
KUCHING, Malaysia, Nov. 28, 2025 -- The Ministry of Education, Innovation and Talent Development Sarawak (MEITD), in collaboration with Borneo Business Connect Sdn Bhd and supported by Business Events Sarawak (BESarawak), today announced the launch of the inaugural Asia Pacific Aerospace Conference & Exhibition (APACE 2026). The event will take place from 27–29 January 2026 at the Borneo Convention Centre Kuching (BCCK). APACE 2026 is a strategic initiative of the Sarawak State Government to position Sarawak as a rising hub for aerospace, aviation, and advanced technology w
- 김갑성 기자
- 2025-11-28 12:22
-
Keep Your Respiratory Health Strong This Season With VARON…
NEW YORK, Nov. 28, 2025 -- As the holiday season approaches, respiratory health becomes a top priority for individuals living with chronic conditions such as COPD, sleep apnea, or other lung diseases. VARON, a leading provider of portable oxygen concentrators and home oxygen concentrators, is officially launching its Black Friday 2025 sale from November 28 through November 30, offering unprecedented sitewide savings, featured deals, and exclusive bundle offers designed to support health and mobility. Comprehensive Savings and Holiday Incentives This year, V
- 김갑성 기자
- 2025-11-28 06:09
-
Strategic Partnership | Sanyou Bio and Korea's FatiAbGen Jo…
SHANGHAI, Nov. 27, 2025 -- Sanyou Biopharmaceuticals (Shanghai) Co., Ltd. ("Sanyou Bio") and South Korea's FatiAbGen Co., Ltd. today jointly announced the signing of a comprehensive strategic collaboration agreement covering joint project development, exclusive representation in the Korean market, and global market expansion. This partnership leverages Sanyou Bio's globally leading AI-STAL drug discovery platform and FatiAbGen's deep local presence in South Korea to drive synergistic growth across Korea, Europe, and beyond — empowering biotech innovators worldwide. The
- 김갑성 기자
- 2025-11-27 22:00
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-12-10_WED
- CNFINANCE ANNOUNCES THE RESULTS OF ITS EXTRAORDINARY GENERAL MEETING 19:15
- 資本の首都から、ADFWが資産運用の次なるフロンティアを描く 18:58
- 이제 유니온페이 카드로 15개 국가에서 애플 서비스 온라인 결제 가능 18:46
- World Gym Corporation (2762.TW) Reports Robust November Revenue Growth and Unveils Ambitious 2026 Strategic Roadmap 18:30
- Admission To Trading on The London Stock Exchange and Completion of Secondary Listing 18:27
- Under the Patronage of His Royal Highness the Crown Prince Governor of Riyadh Region Inaugurates MOMENTUM 2025 Development Finance Conference 17:57
- 엘프바•로스트마리, 2025년 획기적인 R&D 성과 및 새로운 안전 프로토콜 공개 17:22
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 12월 10일 20시 40분